Stay updated on Ligelizumab in CSU Adolescents & Adults Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in CSU Adolescents & Adults Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T22:49:35.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include specific details about a Phase III study on Chronic Spontaneous Urticaria (CSU), including the study's design and blinding procedures, while removing previous descriptions of the study's purpose and inclusion/exclusion criteria.
    Difference
    19%
    Check dated 2025-04-17T07:30:16.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 7, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-10T05:06:32.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous estimated update date of January 7, 2025, and revision version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T22:12:24.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-03-03T22:27:04.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T09:56:16.000Z thumbnail image

Stay in the know with updates to Ligelizumab in CSU Adolescents & Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.